Quarterly report pursuant to Section 13 or 15(d)

Segment Information - Schedule of Segment Information (Details)

v3.24.3
Segment Information - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Dec. 31, 2023
Segment Reporting Information [Line Items]          
Revenues, net $ 3,146 $ 8,365 $ 9,254 $ 40,885  
Cost of revenue 3,311 6,038 10,328 21,590  
Depreciation and amortization expense 1,522 2,571 4,659 4,325  
Operating and other expenses 7,428 6,541 20,653 26,105  
Income (loss) from operations, before income taxes (9,095) (6,785) (26,366) (11,135)  
Income tax benefit 2,508 1,644 7,361 3,104  
Total loss from operations, after income taxes (6,587) (5,141) (19,005) (8,031)  
Net loss (6,587) (5,141) (19,005) (8,031)  
Total assets 91,808   91,808   $ 91,927
Diagnostic services          
Segment Reporting Information [Line Items]          
Revenues, net 0 2,491 0 24,849  
Cost of revenue 501 1,798 1,930 10,812  
Depreciation and amortization expense 719 1,916 2,247 3,059  
Income (loss) from operations, before income taxes (1,520) (2,512) (7,639) 4,902  
Total assets 37,816   37,816   44,221
Consumer products          
Segment Reporting Information [Line Items]          
Revenues, net 3,146 5,874 9,254 16,036  
Cost of revenue 2,810 4,240 8,398 10,778  
Depreciation and amortization expense 803 655 2,412 1,266  
Income (loss) from operations, before income taxes (4,364) (1,384) (7,738) (874)  
Total assets 33,443   33,443   38,358
Unallocated corporate          
Segment Reporting Information [Line Items]          
Income (loss) from operations, before income taxes (3,211) $ (2,889) (10,989) $ (15,163)  
Total assets $ 20,549   $ 20,549   $ 9,348